Please login to the form below
WuXi AppTec
This page shows the latest WuXi AppTec news and features for those working in and with pharma, biotech and healthcare.
Hansoh Pharma shares head skyward after HKEX debut
including BeiGene and WuXi AppTec, after changing regulations to allow companies without revenues or profits to list on the HKEX.
Latest news
-
AZ pushes harder into China with new joint venture
Other investments by AZ in China - now the second-largest pharma market in the world at around $108bn last year - include a strategic alliance with contract research and manufacturing firm WuXi ... AppTec. The decision to invest in the country has
-
AZ takes majority stake in cancer drug developer Acerta
This week it agreed a strategic alliance with WuXi Apptec in China and agreed to buy Takeda's respiratory portfolio.
-
AstraZeneca sets sights on China with Takeda deal
The deal with Chinese contract research and manufacturing firm WuXi AppTec extends an ongoing biologics R&D collaboration between the two companies focused on inflammatory bowel disease candidate MEDI5117, and includes ... an option to buy a
More from news
Approximately 0 fully matching, plus 4 partially matching documents found.
Latest from PMHub
-
WuXi AppTec
Established in December 2000, WuXi AppTec is a leading global pharmaceutical, biopharmaceutical, and medical device outsourcing company with operations in China and the United States. ... As a research-driven and customer-focused company, WuXi AppTec
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
- Top 10 benefits of virtual advisory boards: Save Time and Resources
- NIHR launches new framework to highlight health progress outcomes
- Johns Hopkins and National Cancer Unit develop new genetic risk-scoring method for major diseases
- UKHSA secures UK-based vaccine deal for future influenza pandemics
- Novo Nordisk and Valo Health agree deal worth up to $3.3bn to develop cardiovascular treatments
- Landscape review reveals £1.1bn of UK funding for rare diseases
No results were found
PMHub
CSafe Global
CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...
Latest intelligence
- The importance of accelerating clinical trial diversity
- Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
- Digital Opinion Leaders: The Role of Influencers in Medical Communications
- There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
- Creating Hope Though Action – World Suicide Prevention Day
- At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....
